- CA$6.27m
- -CA$2.28m
- $17.63m
- 35
- 99
- 11
- 46
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.95 | ||
| Price to Tang. Book | 0.95 | ||
| Price to Free Cashflow | 1.02 | ||
| Price to Sales | 0.26 | ||
| EV to EBITDA | -0.26 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 109.41% | ||
| Return on Equity | 857.87% | ||
| Operating Margin | 35% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | 20 | 20.09 | n/a | 17.63 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Titan Medical Inc. is a medical technology company. The Company is focused on the development and commercialization of surgical technologies for single access robotic assisted surgery (RAS) requiring only a single patient access point. It has integrated technology into the Enos surgical system with the purpose of enhancing the robotic assisted surgical experience for surgeons. The Enos surgeon workstation includes a three dimensional (3D) high-definition display to provide a crucial balance of surgical immersion and situational awareness in the operating room. The display is mounted to the ergonomic workstation with a natural handle interface designed to deliver and support comfortable surgical posture, even during long procedures. The Company's multi-articulated instruments bring fluid flexibility and strength to position the end effectors for grasping, suturing, cutting and coagulation.
Directors
- Paul Cataford CHM (57)
- Stephen Lemieux CFO
- Perry Genova SVP
- Chien Huang VFN
- Chris Seibert VPR
- Kristen Galfetti VPR
- Tammy Carrea VPR
- Anthony Giovinazzo LED
- Heather Knight IND
- Cary Vance IND (51)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 28th, 2008
- Public Since
- April 28th, 2008
- No. of Employees
- 4
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Toronto Stock Exchange- Shares in Issue
- 114,039,850
- Address
- 155 University Avenue, Suite 750, TORONTO, M5H 3B7
- Web
- https://www.titanmedicalinc.com/
- Phone
- +1 4165487522
- Auditors
- MNP LLP
Upcoming Events for TMD
Titan Medical Inc Annual Shareholders Meeting
Q2 2024 Titan Medical Inc Earnings Release
Similar to TMD
Bausch + Lomb
Toronto Stock Exchange
Hamilton Thorne
Toronto Stock Exchange
Profound Medical
Toronto Stock Exchange
Sernova
Toronto Stock Exchange
Vitalhub
Toronto Stock Exchange
FAQ
What is the Titan Medical share price?
As of Today at 19:21 UTC, shares in Titan Medical are trading at CA$0.06. This share price information is delayed by 15 minutes.
How has the Titan Medical share price performed this year?
Shares in Titan Medical last closed at CA$0.06 and the price had moved by -76.09% over the past 365 days. In terms of relative price strength the Titan Medical share price has underperformed the Toronto Stock Exchange 300 Composite Index by -77.31% over the past year.
What are the analyst and broker recommendations for Titan Medical?
There is no consensus recommendation for this security.
What is the Titan Medical dividend yield?
Titan Medical does not currently pay a dividend.
Does Titan Medical pay a dividend?
Titan Medical does not currently pay a dividend.
When does Titan Medical next pay dividends?
Titan Medical does not currently pay a dividend.
How do I buy Titan Medical shares?
To buy shares in Titan Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Titan Medical?
As of the previous close price of CA$0.06, shares in Titan Medical had a market capitalisation of CA$6.27m.
Where are Titan Medical shares listed?
Here are the trading details for Titan Medical:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: TMD
What kind of share is Titan Medical?
Based on an overall assessment of its quality, value and momentum Titan Medical is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Titan Medical share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Titan Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Titan Medical. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -64.42%.
As of the last closing price of CA$0.06, shares in Titan Medical were trading -53.56% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Titan Medical PE Ratio?
The Titan Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Titan Medical?
Titan Medical's management team is headed by:
- Paul Cataford - CHM
- Stephen Lemieux - CFO
- Perry Genova - SVP
- Chien Huang - VFN
- Chris Seibert - VPR
- Kristen Galfetti - VPR
- Tammy Carrea - VPR
- Anthony Giovinazzo - LED
- Heather Knight - IND
- Cary Vance - IND